You are subscribed to the Ophthalmology Times eNews.

ASCRS 2015
Twitter Facebook

Download Magazine  | Print & Digital Subscribe  |  eNewsletter Subscribe

Tuesday — November 17, 2015

TOP STORIES

Presbyopia treatment aims to rejuvenate 'lazy' ciliary muscles

Microelectrostimulation of the ciliary body is a promising non-invasive technique for restoring accommodative loss in eyes with early presbyopia, said Luca Gualdi, MD. » How it works

Femtosecond laser-enabled approach allows treatment of high astigmatism

Femtosecond laser intrastromal arcuate keratotomy (AK) under a corneal flap is feasible and appears to be safe and effective for reducing high astigmatism, according to the early experience of António Limã, MD.
» Learn more

Study provides insight on long-term outcomes after hyperopic LASIK

Hyperopic LASIK (H-LASIK) has limited predictability and declining efficacy during long-term follow-up, but its safety remains good and patient satisfaction stays high, said Reena Mahendra Dave, MD. » About the study

Anti-interleukin-6 agent for treatment of uveitis promising

Intravenous administration of the anti-interleukin-6 (IL-6) agent tocilizumab (Actemra, Genentech) is well-tolerated in patients with non-infectious uveitis involving the posterior segment and showing promising efficacy, according to interim outcomes reported by Quan Dong Nguyen, MD. » See the outcomes

AAO ‏@aao_ophth

"You control your data." Bill Rich, MD at the IRIS Registry session, booth 2632 #AAO2015  

Howard ‏@neuroophp

#AAO2015  come learn what is new about ischemic optic neuropathy in Hall D in Tony Arnold's keynote address

Romeo Hurtado ‏@RomeoHurtado

#aao2015 To see one's gratitude smile is the best reward I can get in my private practice

Top Tweets

We welcome your feedback!
Please send your comments to:

Mark L. Dlugoss

Group Content Director

UBM Medica Eyecare Group

mark.dlugoss@ubm.com

DISCLAIMER:
This information has been independently developed and provided by the editors of Ophthalmology Times.
The sponsors do not endorse and are not responsible for the accuracy of the content or for practices or standards of non-sponsor sources. These articles may discuss regimens that have not been approved by the FDA.
For full prescribing information including indications, contraindications, warnings, precautions, and adverse experiences, please see the appropriate manufacturer's product circular.

Editorial Questions? Contact the Editorial Team Click Here. Sales, Reprints, Classified questions? Contact the Sales Team Click Here.

ModernMedicine logoUBM Advanstar logo